[Endocervical epithelial changes in internal uterine endometriosis treated with bisekurin].
D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects*; D003277:Contraceptives, Oral, Combined; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy*; D004848:Epithelium / Q000187:drug effects; D005040:Ethynodiol Diacetate / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D008656:Mestranol / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D009092:Mucous Membrane / Q000187:drug effects; D045167:Progesterone Congeners / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D003277:Contraceptives, Oral, Combined; D045167:Progesterone Congeners; D005040:Ethynodiol Diacetate; C018467:Bisecurin I; D008656:Mestranol
Izmeneniia éndotservikal'nogo épiteliia u bol'nykh vnutrennim éndometriozom matki pri lechenii bisekurinom.